SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005079
Filing Date
2023-02-28
Accepted
2023-02-28 16:09:15
Documents
93
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sndx-20221231.htm   iXBRL 10-K 3907582
2 EX-10.24 sndx-ex10_24.htm EX-10 19030
3 EX-21.1 sndx-ex21_1.htm EX-21 6939
4 EX-23.1 sndx-ex23_1.htm EX-23 5108
5 EX-31.1 sndx-ex31_1.htm EX-31 18105
6 EX-31.2 sndx-ex31_2.htm EX-31 18098
7 EX-32.1 sndx-ex32_1.htm EX-32 18860
8 GRAPHIC img206251547_0.jpg GRAPHIC 190256
9 GRAPHIC img206251547_1.jpg GRAPHIC 123912
10 GRAPHIC img206251547_2.jpg GRAPHIC 54373
11 GRAPHIC img206251547_3.jpg GRAPHIC 90642
12 GRAPHIC img206251547_4.jpg GRAPHIC 72701
  Complete submission text file 0000950170-23-005079.txt   14425835

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sndx-20221231_def.xml EX-101.DEF 310650
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sndx-20221231_cal.xml EX-101.CAL 63992
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20221231_pre.xml EX-101.PRE 497401
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20221231_lab.xml EX-101.LAB 679140
17 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20221231.xsd EX-101.SCH 84064
87 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20221231_htm.xml XML 2445967
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37708 | Film No.: 23685259
SIC: 2834 Pharmaceutical Preparations